Centene (Centene) ROCE %

: 1.73% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Centene's annualized ROCE % for the quarter that ended in Dec. 2023 was 1.73%.

Centene ROCE % Historical Data

The historical data trend for Centene's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centene Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

9.34

9.31

4.97

5.20

8.98

Centene Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %																1.75	12.76	12.56	7.66	1.73

Centene ROCE % Calculation

Centene's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	4323	/	( ( (76870 - 28464)	+	(84641 - 36716) )	/ 2 )
	=	4323	/	( (48406	+	47925)	/ 2 )
	=	4323	/	48165.5
	=	8.98 %

Centene's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	828	/	( ( (84381 - 36851)	+	(84641 - 36716) )	/ 2 )
	=	828	/	( ( 47530	+	47925 )	/ 2 )
	=	828	/	47727.5
	=	1.73 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Centene (NYSE:CNC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Centene ROCE % Related Terms

Thank you for viewing the detailed overview of Centene's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Centene (Centene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Centene Corp (NYSE:CNC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

CNC:Mexico 1CNC:Italy QEN:Germany QEN:Germany C1NC34:Brazil

Address

7700 Forsyth Boulevard, Centene Plaza, St. Louis, MO, USA, 63105

Website

https://www.centene.com

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.

Executives

Lori Jean Robinson	director	5875 LANDERBROOK DRIVE, SUITE 220, CLEVELAND OH 44124
Andrew Lynn Asher	officer: EVP, CFO	8735 HENDERSON ROAD, TAMPA FL 33634
James E Murray	officer: EVP, Chief Transform. Officer	500 WEST MAIN STREET, LOUISVILLE KY 40202
Samuels Theodore R. Ii	director	1990 E. GRAND AVE., EL SEGUNDO CA 90245
Monte E Ford	director	C/O AKAMAI TECHNOLOGIES, INC., 8 CAMBRIDGE CENTER, CAMBRIDGE MA 02142
Kenneth J Fasola	officer: EVP, Health Care Enterprises	500 WEST MAIN STREET, LOUISVILLE KY 40202
Shannon Bagley	officer: EVP, Chief Admin. Officer	7700 FORSYTH BOULEVARD, CLAYTON MO 63105
Richard A Gephardt	director	822 CAPITOL SQUARE PLACE, SW, WASHINGTON DC 20024
Christopher J Coughlin	director
H James Dallas	director	127 PUBLIC SQUARE, CLEVELAND OH 44114
Mark J Brooks	officer: SVP, Chief Information Officer	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
David P Thomas	officer: EVP, MARKETS	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105
Leslie V Norwalk	director	C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Wayne S Deveydt	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Toney Colin A	officer: EVP, Mergers & Acquisitions	7700 FORSYTH BOULEVARD, ST. LOUIS MO 63105